Inventor
Robert L. Martuza
Inventor
Chevy Chase, MD, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C12NMicroorganisms or enzymes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
A01KAnimal husbandry11%
C07KPeptides9%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,532,095Viral vectors and their use in therapeutic methods20209,827,307Use of herpes vectors for tumor therapy20179,555,072'Viral vectors and their use in therapeutic methods'20178,871,193'Viral vectors and their use in therapeutic methods'20148,703,120'Use of oncolytic herpes viruses for killing cancer stem cells'20148,470,577'Viral vectors and their use in therapeutic methods'20138,361,978'Use of herpes vectors for tumor therapy'20138,313,896'Oncolytic herpes simplex virus immunotherapy in the treatment of brain cancer'20128,273,568'Replication-competent herpes simplex virus mediates destruction of neoplastic cells'20127,749,745'Viral vectors and their use in therapeutic methods'20107,064,111'Use of soluble costimulatory factor for tumor immuno-gene therapy'20066,770,274'Viral mutant HSV mediated destruction of neoplastic cells'20046,699,468'Replication-competent herpes simplex virus mediates destruction of neoplastic cells'20046,610,287'Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication'20036,555,108'Implanting HSV-TK retrovirus producing cells to treat tumors'20036,537,541'Implantation of HSV-TK retrovirus producer cells to destroy glioma'20036,379,674'Use of herpes vectors for tumor therapy'20026,362,392'Nude mouse model for the growth and treatment of human neurally-derived tumors'20026,139,834'Replication-competent Herpes simplex virus mediates destruction of neplastic cells'20006,090,794'Inhibition of neurofibrosarcoma growth and angiogenesis'20005,728,379'Tumor- or cell-specific herpes simplex virus replication'19985,585,096'Replication-competent herpes simplex virus mediates destruction of neoplastic cells'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2020Patents assigned to UNIV GEORGETOWN (14)· patent assignee history
1996–2013Based in Chevy Chase, MD, US· patent location history
2000–2014Patents assigned to GEN HOSPITAL CORP (11)· patent assignee history
2000–2003Based in Lexington, MA, US· patent location history
2006–2020Based in Cambridge, MA, US· patent location history
2012–2013Patents assigned to MARTUZA ROBERT L (4)· patent assignee history
2012–2013Patents assigned to RABKIN SAMUEL D (3)· patent assignee history
2012–2014Based in Marblehead, MA, US· patent location history
2013–2020Patents assigned to CATHEREX INC (4)· patent assignee history
2017Based in Marble Head, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV GEORGETOWN | 14 | 1996–2020 |
| GEN HOSPITAL CORP | 11 | 2000–2014 |
| CATHEREX INC | 4 | 2013–2020 |
| MARTUZA ROBERT Lself | 4 | 2012–2013 |
| RABKIN SAMUEL D | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Chevy Chase, Maryland, US | 10 | 1996–2013 |
| Cambridge, Massachusetts, US | 6 | 2006–2020 |
| Lexington, Massachusetts, US | 3 | 2000–2003 |
| Marblehead, Massachusetts, US | 2 | 2012–2014 |
| Marble Head, Massachusetts, US | 1 | 2017 |